Correlation Between Berkshire Hathaway and AstraZeneca PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Berkshire Hathaway and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Berkshire Hathaway and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Berkshire Hathaway and AstraZeneca PLC, you can compare the effects of market volatilities on Berkshire Hathaway and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Berkshire Hathaway with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Berkshire Hathaway and AstraZeneca PLC.

Diversification Opportunities for Berkshire Hathaway and AstraZeneca PLC

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Berkshire and AstraZeneca is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Berkshire Hathaway and AstraZeneca PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC and Berkshire Hathaway is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Berkshire Hathaway are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC has no effect on the direction of Berkshire Hathaway i.e., Berkshire Hathaway and AstraZeneca PLC go up and down completely randomly.

Pair Corralation between Berkshire Hathaway and AstraZeneca PLC

Assuming the 90 days trading horizon Berkshire Hathaway is expected to generate 0.71 times more return on investment than AstraZeneca PLC. However, Berkshire Hathaway is 1.41 times less risky than AstraZeneca PLC. It trades about 0.38 of its potential returns per unit of risk. AstraZeneca PLC is currently generating about -0.07 per unit of risk. If you would invest  40,430  in Berkshire Hathaway on September 3, 2024 and sell it today you would earn a total of  5,500  from holding Berkshire Hathaway or generate 13.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Berkshire Hathaway  vs.  AstraZeneca PLC

 Performance 
       Timeline  
Berkshire Hathaway 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Berkshire Hathaway are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, Berkshire Hathaway is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.
AstraZeneca PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AstraZeneca PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's technical and fundamental indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Berkshire Hathaway and AstraZeneca PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Berkshire Hathaway and AstraZeneca PLC

The main advantage of trading using opposite Berkshire Hathaway and AstraZeneca PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Berkshire Hathaway position performs unexpectedly, AstraZeneca PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will offset losses from the drop in AstraZeneca PLC's long position.
The idea behind Berkshire Hathaway and AstraZeneca PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance